ConductScience.org, home

Paper9593151

Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.

Klepser ME and 4 others. Antimicrob Agents Chemother, 1998. Cited by 257 papers, by iCite.

Cite this record

ConductScience Library. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Papers, record 9593151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9593151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
257
iCite
Relative citation ratio, by iCite
8.59
iCite
Revised in PubMed
2022-03-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klepser MEM E
2Ernst EJE J
3Lewis RER E
4Ernst MEM E
5Pfaller MAM A

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
CandidaMajor topic
Microbial Sensitivity TestsMajor topic
Colony Count, Microbial
Drug Evaluation
Research Design

References7

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17447427Method of reliable determination of minimal lethal antibiotic concentrations.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7447427PubMed
29078447Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp.Diagn Microbiol Infect Dis1996https://conductscience.org/library/papers/9078447PubMed
39087485In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9087485PubMed
49578168Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B against Cryptococcus neoformans.J Antimicrob Chemother1998https://conductscience.org/library/papers/9578168PubMed
59174207Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9174207PubMed
69458979Growth medium effect on the antifungal activity of LY 303366.Diagn Microbiol Infect Dis1997https://conductscience.org/library/papers/9458979PubMed
79114154
Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Clin Infect Dis1997https://conductscience.org/library/papers/9114154PubMed

Download CSV of references

Cited by128

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 257 citations.

PMIDTitleJournalYearIn PapersSource
42931223Effects of Sanghuang Extract on Candida albicans Colonization and Intestinal Inflammation in a DSS-Induced Colitis Mouse Model.Pathogens2026https://conductscience.org/library/papers/42931223PubMed
42540316An Organoselenium Compound Induces Death in Cryptococcus gattii Yeast by Apoptosis and Necrosis and Shows Antifungal Efficacy in Galleria mellonella.ACS Omega2026https://conductscience.org/library/papers/42540316PubMed
42518468Novel Inhibitors Targeting Urease Promote Fungicidal and Antivirulence Effects in Cryptococcus.ACS Omega2026https://conductscience.org/library/papers/42518468PubMed
42346571In Vitro Evaluation of Olorofim and Amphotericin B Combination Therapy Against Talaromyces marneffei.J Fungi (Basel)2026https://conductscience.org/library/papers/42346571PubMed
42289527Microbial biotransformation of Syzygium australe modifies metabolomic profile assessed with multivariate analysis and molecular networking: In vitro and computational studies.Sci Rep2026https://conductscience.org/library/papers/42289527PubMed
42223519Rapid exploration of anti-MRSA components from plants of Salvia.Nat Prod Bioprospect2026https://conductscience.org/library/papers/42223519PubMed
42198433Candicidal Effect of a Nanoemulsion Based on the Essential Oil of the Medicinal Plant Haplopappus foliosus: Role of Main Compounds in Yeast Inhibition.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42198433PubMed
42047263Synergistic antibacterial activity and mechanism of arginine combined with florfenicol against Escherichia coli.Virulence2026https://conductscience.org/library/papers/42047263PubMed
41704551Anti-Shigella activity and killing kinetics of compounds from MMV Pathogen and COVID Boxes: Identifying leads against Shigellosis.Curr Res Pharmacol Drug Discov2026https://conductscience.org/library/papers/41704551PubMed
41476504Targeting Non-albicans Candida Strains and Phytopathogenic Fusarium Species with Chitooligosaccharides: Insights into the Antifungal Mechanism.ACS Omega2025https://conductscience.org/library/papers/41476504PubMed
41474803In vitro evidence to support amphotericin B and flucytosine combination therapy for talaromycosis.PLoS Negl Trop Dis2025https://conductscience.org/library/papers/41474803PubMed
41040159In Vitro Evidence to Support Amphotericin B and Flucytosine Combination Therapy for Talaromycosis.bioRxiv2025https://conductscience.org/library/papers/41040159PubMed
40952940Biocompatible Guanidine-Functionalized Compounds with Biofilm and Membrane Disruptive Activity Against MRSA.ACS Infect Dis2025https://conductscience.org/library/papers/40952940PubMed
40893255Bixin from Bixa orellana L.: Analytical Method Validation, Physicochemical Characterization, and Selective Antifungal Activity against Candida spp. .ACS Omega2025https://conductscience.org/library/papers/40893255PubMed
40872309Chemical Composition, Biocompatibility, and Anti-Candida albicans Activity of Schinus weinmanniifolia Mart. ex Engl.Pathogens2025https://conductscience.org/library/papers/40872309PubMed
40871505Synergistic Antibacterial Effect of Eugenol and Biogenic Silver Nanoparticles on Staphylococcus pseudintermedius Isolated from Canine Keratoconjunctivitis Sicca.Molecules2025https://conductscience.org/library/papers/40871505PubMed
40219128Synergistic Antibacterial Interaction of Geraniol and Biogenic Silver Nanoparticles on Methicillin-Resistant Staphylococcus aureus.Plants (Basel)2025https://conductscience.org/library/papers/40219128PubMed
39863777
Therapeutic alternatives for sporotrichosis induced by wild-type and non-wild-type Sporothrix schenckii through in vitro and in vivo assessment of enilconazole, isavuconazole, posaconazole, and terbinafine.
Sci Rep2025https://conductscience.org/library/papers/39863777PubMed
39673050Chemical profile, antioxidant, antifungal, and cytotoxic activities of propolis from the stingless bee Tetragona clavipes.Braz J Microbiol2025https://conductscience.org/library/papers/39673050PubMed
39617796Synthesis, characterization, quantum chemical modelling, molecular docking, in silico and in vitro assessment of 3-(2-bromo-5-fluorophenyl))-1-(thiophen-2-yl)prop-2-en-1-one.Sci Rep2024https://conductscience.org/library/papers/39617796PubMed

See all 128 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9593151

GET https://conductscience.org/api/papers/v1/9593151/cited_by?page=2